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Clinical aspects
Chronic kidney disease (CKD) can be considered 
to be present if a patient has a glomerular filtration 
rate (GFR) <60 mL/min or markers of kidney disease 
that have been present for >3 months. These include 
proteinuria, haematuria and radiological abnormalities. Regardless 
of the stage of CKD, the approach is mainly similar. As stated in 
the South African Renal Society Guidelines for the early detection 
and management of CKD, early and appropriate investigation and 
timeous referral of these patients enable one to:
• Establish a specific diagnosis and treat reversible diseases.
• Optimise management to slow the progression of CKD.
• Identify and optimally manage comorbid conditions.
• Plan renal replacement therapy well before the patient develops 
end-stage kidney disease.
History
As with any facet of clinical medicine, the clinician starts by taking a 
sound medical history. This is especially important with CKD, as the 
clinical manifestations are often subtle and insidious.
Past history
Patients may volunteer a history of definite kidney disease; if not, one 
should enquire about the following:
• a history of periorbital or peripheral oedema
• bouts of macroscopic haematuria in relation to viral infections 
(suggestive of immunoglobulin dimer isotype A (IgA) nephropathy)
• recurrent urinary tract infections (vesico-ureteric reflux or 
anatomical abnormalities)
• a past history of acute renal failure
• symptoms of prostatism.
One should enquire routinely about a past history of hypertension, 
diabetes, gout, renal calculi, collagen vascular disease and chronic 
inflammatory diseases, such as rheumatoid arthritis. 
Any chronic painful condition, such as chronic headache, back-
ache, osteoarthritis and dysmenorrhoea, may be significant, as they 
may result in excessive chronic analgesic intake. 
• Drug history. The drugs most commonly responsible for CKD are 
non-steroidal anti-inflammatory drugs and compound analgesics. 
Remember lithium in patients with bipolar disorders. Angiotensin-
converting enzyme inhibitors and angiotensin II receptor blockers 
tend to cause acute or subacute deterioration of renal function in 
patients with CKD.
• Past laboratory data. Having access to previous laboratory and 
radiological investigations is particularly important in CKD, as 
it enables the doctor to confirm chronicity and assess the rate of 
progression of the disease.
• Pregnancy. A history of pregnancy-induced hypertension (in the 
second or third pregnancies) or early-onset pre-eclampsia suggests 
pre-existing hypertension or CKD.
• Family history. A family history of kidney failure or nephrotic 
syndrome may suggest disorders such as polycystic kidney disease, 
Alport syndrome, focal segmental glomerulosclerosis and IgA 
nephropathy. A family history of hypertension, diabetes and the 
metabolic syndrome assists with the evaluation of the patient’s 
cardiovascular risk profile. 
• Current symptoms. A history of anorexia, nausea, weight loss, 
weakness, impaired effort tolerance, nocturia and muscle cramps 
suggests chronicity.
Physical examination
Although the clinical features of CKD are nonspecific, the examination 
may reveal the following:
• General. Periorbital and/or peripheral oedema, pallor, gouty 
tophi, arthritis, signs of collagen vascular disease and macroglossia 
(amyloidosis).
• Cardiovascular. Hypertension, particularly with clinical evidence 
of established hypertension. Ejection systolic murmurs (anaemia) 
and a pericardial friction rub (uraemia).
• Chest. Pulmonary oedema suggests advanced CKD and pleural 
effusions occur in patients with nephrotic syndrome.
• Abdomen. Palpable kidneys (polycystic kidney disease), hepato-
megaly (amyloidosis), bruits (renal artery stenosis).
• Fundoscopy. Hypertensive and diabetic retinopathy.
• Prostate gland. Hypertrophy.
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• Central nervous system. Overt confusion 
or more subtle impair ment of intellectual 
functions. Generalised muscle weakness, 
asterixis and sensory-motor peripheral 
neuropathy.
Special investigations
Investigations are conducted to (i) ascertain 
the cause of the CKD; and (ii) assess the 
severity and chronicity of the disease.
Laboratory investigations
• A urine examination is mandatory in 
all cases, i.e. dipstick, microscopy and 
quantitation of protein excretion. The last 
can be measured on a random specimen by 
calculating the protein/creatinine ratio. An 
‘active’ urine sediment with microscopic 
haematuria and red cell casts suggests an 
underlying glomerulonephritis.
• Further tests to assist with the diagnosis 
include antinuclear antibody profile, 
antineutrophil cytoplasmic antibody, 
C-reactive protein, cryoglobulins, serum 
complement, hepatitis B and C profile, 
HIV, venereal disease research laboratory 
test and uric acid levels. Serum/urine 
protein electrophoresis and serum 
Freelite assay should be done in patients 
>40 years of age with unexplained 
CKD and anaemia in order to exclude 
paraproteinaemia. 
• Tests to determine the severity of the CKD 
and associated metabolic/haematological 
abnormalities include: urea and electro lytes, 
serum creatinine and estimated GFR. The 
last may be cal culated by the Cockcroft-
Gault or modification of diet in renal disease 
(MDRD) formula or by measuring the 
24-hour urinary creatinine clearance.
• Other tests include: full blood count, serum 
calcium, phosphate and iron studies. 
Alkaline phosphatase and parathyroid 
hormone levels are measured to assess the 
presence of renal osteodystrophy.
Radiological investigations
The most cost-effective examination is renal 
ultrasonography. This should be performed 
in all patients and the documentation of small 
echogenic kidneys supports the diagnosis of 
CKD. However, the presence of normal-sized 
kidneys, while suggesting acute renal disease, 
does not exclude CKD. Ultrasound is also 
useful for diagnosing obstructive uropathy 
and may detect asymmetrical kidney size, 
suggesting possible renovascular disease.
Other important investigations include:
• Voiding cysto-urethrography to rule out 
vesico-ureteric reflux.
• A computed tomography (CT) scan (also 
known as the computed axial tomography 
(CAT) scan) without contrast in patients 
with suspected renal calculi.
• Magnetic resonance angiography, CT 
angiography or a radio-isotope study for 
suspected renal artery stenosis.
In general, the clinician should – if possible 
– avoid exposing the patient to intravenous 
radio-contrast agents because of their 
nephrotoxicity.
Kidney biopsy
The following are indications for a kidney 
biopsy:
• Patients with CKD whose kidneys are 
normal or near normal in size, where the 
diagnosis cannot be made by other means.
• Patients with a definite diagnosis, where 
the histology is essential for appropriate 
management and prognosis, e.g. lupus 
nephritis, vasculitis.
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Fig. 1. Urine dipstick screening for renal disease. (U/E = urea and electrolytes; eGFR = estimated 
glomerular filtration rate.)  
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Fig. 2. Management of positive haematuria screening. 
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• Patients with an established diagnosis, such as diabetic nephropathy, 
who have unexplained deterioration of kidney function. 
Contraindications to kidney biopsy include bilateral small kidneys, 
uncontrolled hypertension, urinary tract or perinephric infection, 
polycystic kidneys and a bleeding diathesis. 
Significance and evaluation of urine 
tests
A urine test at the bedside or in a clinic (urine dipstick) is a valuable 
screening and management tool. 
Key findings are:
• proteinuria
• haematuria
• leucocyturia and nitrites
• other.
Proteinuria. The role of proteinuria testing using urine dipsticks, is 
key in the screening for renal diseases. 
• A proteinuria >3+ is most likely of glomerular origin. Proteinuria 
is toxic to the tubules; hence it may lead to renal failure. 
• Proteinuria of 2+ or 1+ is significant and needs to be further 
quantified to estimate the 24-hour protein loss. This can be further 
quantified by measuring the protein/creatinine ratio. Timed urine 
collections, traditionally for 24 hours, are cumbersome and often 
inaccurate. These can now be replaced by the more convenient 
spot urine protein/creatinine ratio. A positive proteinuria test 
needs to be repeated to minimise the non-significant proteinuria 
found during heavy exercise, fever and stress.
• Common significant proteinuria is found in pyelonephritis, 
glomerulonephritis, nephrotic syndrome, diabetes, pre-eclampsia, 
HIV associated nephropathy, congestive heart failure and 
malignant hypertension. 
Haematuria. If a urine dipstick is positive for blood, this needs to 
be confirmed by urine microscopy, as a urine dipstick test cannot 
distinguish blood from haemoglobinuria or myoglobinuria. 
• Haematuria, and proteinuria, can be of renal or post-renal origin. 
• Haematuria is associated with urethral causes (stricture, trauma), 
bladder causes (infections, tumour, trauma, stones) or ureteric 
(stones) renal causes, including glomerulonephritis, interstitial 
nephritis, tumours and trauma.
• A combination of proteinuria and haematuria may help to define 
the diagnosis of a condition, e.g. a diabetic patient is expected to 
have pure proteinura owing to diabetic nephropathy. Additional 
haematuria may prompt investigation for other causes, including 
pyelonephritis. 
Leucocyturia and nitrites 
• Leucocyturia often indicates infection anywhere in the urinary 
tract; when combined with a positive nitrite test, it is associated 
with infection in three-quarters of cases. 
• Persistent leucocyturia could be associated with the tubercle 
bacillus, renal stones or interstitial nephritis. 
• A urine culture needs to be performed to diagnose the causal 
organism, followed by an antimicrobial sensitivity test. 
Other useful tests. More tests are available on some urine dipsticks; 
these may include pH and specific gravity, which are useful for the 
assessment of patients with acidosis and dehydration.  
Figs 1 and 2 show algorithms that may assist in the management of 
a patient with proteinuria and/or haematuria.
Essential renal function tests
The serum creatinine – not the serum urea – is the most essential 
measurement. Taken alone, a mere creatinine level is not sufficient 
to estimate kidney function. A normal creatinine in a thin and 
especially elderly female, i.e. those with reduced muscle mass, could 
represent significant renal failure. Therefore, all patients who are at 
risk of CKD should have an eGFR.[1] The previously discussed MDRD 
formula is more routinely available from all pathology laboratories in 
South Africa and laboratories express the eGFR as correlated to the 
definitions of CKD.
If 24-hour urine collection is to be used to estimate the GFR, there 
are two prerequisites: (i) if the doctor explains to the patient what is 
required, an accurate 24-hour collection can usually be obtained, but 
only as an outpatient; (ii) creatinine clearance overestimates stages 
1 - 4 CKD. Accurate clearance can be obtained by measuring the 
24-hour urine collection (creatinine and urea clearances, adding them 
together and dividing by 2) (B Goldburg – personal communication). 
Whichever method is used, the eGFR not only stages the CKD but 
is essential in monitoring progress over time. eGFR tests should 
be performed more frequently in potentially high-risk and elderly 
persons. 
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